On February 27, 2018 Pfenex Inc. (NYSE AMERICAN: PFNX), reported that the company will present at Barclay’s 2018 Global Healthcare Conference in Miami Beach, Florida (Press release, Pfenex, FEB 27, 2018, View Source2018-02-27-Pfenex-Inc-to-Present-at-Barclays-2018-Global-Healthcare-Conference" target="_blank" title="View Source2018-02-27-Pfenex-Inc-to-Present-at-Barclays-2018-Global-Healthcare-Conference" rel="nofollow">View Source [SID1234524255]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
President and Chief Executive Officer, Eef Shimmelpennink, is scheduled to present on Tuesday, March 13th at 3:50 pm ET.
Interested parties can access the live audio webcast for this presentation from the Investors Section of Pfenex’s website at www.pfenex.com. The webcast replay will be available after the conclusion of the live presentation for approximately 60 days.
Pfenex investors and others should note that we announce material information to the public about the Company through a variety of means, including our website (View Source), our investor relations website (View Source), press releases, SEC filings, public conference calls, corporate Twitter account (View Source), Facebook page (View Source), and LinkedIn page (View Source) in order to achieve broad, non-exclusionary distribution of information to the public and to comply with our disclosure obligations under Regulation FD. We encourage our investors and others to monitor and review the information we make public in these locations as such information could be deemed to be material information. Please note that this list may be updated from time to time.